WolverHeme Happy Hour

Bernard Marini, Anthony Perissinotti, et al.
  • 0.0 (0)
  • MEDICINA
  • CADA MES

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

  1. 17/12/2025

    ASH Leukemia Review: the more we learn, the less we know!

    In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia in 2025! What abstracts should change practice? Listen to find out. Some of the abstracts discussed: PARADIGM: https://meetings-api.hematology.org/api/abstract/vmpreview/296881KMT2A Outcomes (MARROW Consortium and Othman, et al.): https://meetings-api.hematology.org/api/abstract/vmpreview/302582 and https://meetings-api.hematology.org/api/abstract/vmpreview/297333CLIA +/- Ven: https://meetings-api.hematology.org/api/abstract/vmpreview/302047FLT3i studies (and MRD): https://meetings-api.hematology.org/api/abstract/vmpreview/295719 and https://meetings-api.hematology.org/api/abstract/vmpreview/302699 and https://meetings-api.hematology.org/api/abstract/vmpreview/291322ALL GIMEMA Trial (blin + ponatinib): https://meetings-api.hematology.org/api/abstract/vmpreview/296532Menin inhibitor data

    1 h y 23 min

  2. 09/12/2025

    RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy

    Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice.  https://meetings-api.hematology.org/api/abstract/vmpreview/296881

    41 min

  3. 25/11/2025

    MajesTEC-3 and ASH 2025: Let's get "TEC"nical

    In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3 study!

    1 h y 10 min

  4. 24/10/2025

    Episode 40: Coffee and Community Hematology

    In this episode, Anthony and Bernie discuss the important role of community hematology. We discuss innovative research models, partnerships between community and academic practices, and ways to improve care for hematology patients who live near and far!

    51 min

  5. 09/10/2025

    Chill For 5: The Febrile Neutropenia Survival Guide

    In this episode, Bernie and Anthony review the optimal management of febrile neutropenia! We talk about some historical data, optimal patient workup, proper selection of antibiotics, and a discussion of newer data regarding early antibiotic de-escalation in FN.

    49 min

  6. 10/09/2025

    Episode 38: Prophy and Pints!

    We're back after a summer break! In this episode, Anthony and Bernie review the optimal approach to antimicrobial prophylaxis in hematology patients. How do you best choose prophylaxis for your patients? Where are we using data and where are we just making things up? Does everyone need antifungal, antibacterial, antiviral, and anti-PJP prophylaxis? We will demystify prophylaxis guidelines for you!

    50 min

  7. 11/07/2025

    Episode 37: Spilling Drinks over Cytarabine Dosing

    In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your practice? Hunault, et al. NEJM. 2025. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2400326

    59 min

  8. 28/05/2025

    Episode 36: ODAC - Our Decisions Are Confusing

    In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!

    43 min
Ver todo (44)

Acerca de

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Información

  • Creador
    Bernard Marini, Anthony Perissinotti, et al.
  • Años de actividad
    2022 - 2025
  • Episodios
    44
  • Clasificación
    Explícito
  • Copyright
    © Bernard Marini, Anthony Perissinotti, et al.
  • Mostrar sitio web
    WolverHeme Happy Hour

También te podría interesar